|
| 皓元医药(688131)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-07-25 | 11.90 | 0.06% | 21042.33 | 11.90 | 20576.33 | 97.73% | 股权激励限售股份 | | 2025-04-30 | 454.09 | 2.16% | 21030.43 | 23.80 | 20576.33 | 97.73% | 定向增发机构配售股份 | | 2024-07-11 | 90.98 | 0.60% | 14560.84 | 477.89 | 14632.40 | 97.30% | 定向增发机构配售股份 | | 2024-06-11 | 5983.88 | 39.83% | 14615.40 | 406.34 | 8631.37 | 57.46% | 首发原股东限售股份 | | 2023-12-22 | 17.15 | 0.11% | 8648.52 | 6390.22 | 8631.37 | 57.39% | 定向增发机构配售股份 | | 2023-06-08 | 145.82 | 0.97% | 8631.37 | 6390.36 | 8496.83 | 56.56% | 首发战略配售股份 | | 2023-05-19 | 31.58 | 0.29% | 6069.16 | 4660.65 | 6069.16 | 56.56% | 股权激励一般股份 | | 2022-06-08 | 2706.30 | 36.40% | 4306.80 | 3127.40 | 4306.80 | 57.93% | 首发原股东限售股份,首发战略配售股份 | | 2021-12-08 | 75.99 | 1.02% | 1704.11 | 5730.09 | 1704.11 | 22.92% | 首发机构配售股份 |
|